Clinical Trial Update: GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of GB5005 CART-cell injection targeting CD19 in patients with relapsed or refractory B-cell non-Hodgkin lym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• GB5005 CART-cell injection

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Non-hodgkin Lymphoma, Refractory Lymphoma | Phase 1 | Status: RECRUITING